Managers / Q1 2023 · view latest →
DSC Advisors, L.P.
CIK 0001299434 · 900 NORTH MICHIGAN AVENUE, SUITE 1600, CHICAGO, IL, 60611 · (312) 915-2485
Summary
Dsc Advisors, L.P. reported $115M in U.S.-listed holdings across 24 positions for Q1 2023.
Its largest position, R1 Rcm, represents 13.0% of the portfolio.
Compared with Q4 2022, the fund opened 8 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 53.4% · $61M
- ETP · 45.2% · $52M
- ADR · 1.4% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| QQQINVESCO QQQ TR | NEW | +160.0K | 160.0K | +$51M | $51M |
| APOAPOLLO GLOBAL MGMT INC | NEW | +165.0K | 165.0K | +$10M | $10M |
| TEVATEVA PHARMACEUTICAL INDS LTD | NEW | +180.0K | 180.0K | +$2M | $2M |
| VYNEVYNE THERAPEUTICS INC | NEW | +115.0K | 115.0K | +$354,200 | $354,200 |
| DISHDISH NETWORK CORPORATION | NEW | +30.0K | 30.0K | +$279,900 | $279,900 |
| TBTPROSHARES TR | NEW | +10.0K | 10.0K | +$279,600 | $279,600 |
| CRMSALESFORCE INC | NEW | +1.1K | 1.1K | +$210,568 | $210,568 |
| MSOSADVISORSHARES TR | NEW | +27.5K | 27.5K | +$156,475 | $156,475 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | R1 RCM INC | COM | 12.96% | $15M | 990.0K |
| 2 | CVSCVS HEALTH CORPhistory → | COM | 8.45% | $10M | 130.3K |
| 3 | BMRNBIOMARIN PHARMACEUTICAL INChistory → | COM | 7.85% | $9M | 92.5K |
| 4 | ZBHZIMMER BIOMET HOLDINGS INChistory → | COM | 7.05% | $8M | 62.5K |
| 5 | GOOGALPHABET INC | CAP STK CL C · CAP STK CL A | 4.49% | $5M | 49.5K |
| 6 | EHTHEHEALTH INChistory → | COM | 1.57% | $2M | 192.5K |
| 7 | TEVATEVA PHARMACEUTICAL INDS LTDhistory → | SPONSORED ADS | 1.39% | $2M | 180.0K |
| 8 | MSFTMICROSOFT CORP | COM | 0.31% | $360,375 | 1.3K |
| 9 | VYNEVYNE THERAPEUTICS INC | COM | 0.31% | $354,200 | 115.0K |
| 10 | METAMETA PLATFORMS INC | CL A | 0.25% | $285,059 | 1.3K |
| 11 | TBTPROSHARES TR | PSHS ULTSH 20YRS | 0.24% | $279,600 | 10.0K |
| 12 | VVISA INC | COM CL A | 0.21% | $235,606 | 1.0K |
| 13 | AAPLAPPLE INC | COM | 0.20% | $232,179 | 1.4K |
| 14 | MAMASTERCARD INCORPORATED | CL A | 0.20% | $226,041 | 622 |
| 15 | CRMSALESFORCE INC | COM | 0.18% | $210,568 | 1.1K |
| 16 | MSOSADVISORSHARES TR | PURE US CANNABIS | 0.14% | $156,475 | 27.5K |
| 17 | DISHDISH NETWORK CORPORATION | CL A | 0.12% | $139,950 | 15.0K |
| 18 | QQQINVESCO QQQ TR | UNIT SER 1 | 0.01% | $13,158 | 41 |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $11M | 19 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $30M | 24 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $63M | 34 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $61M | 32 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $78M | 33 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $67M | 31 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $115M | 24 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $44M | 17 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $97M | 97 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $100M | 113 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $290M | 132 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $129M | 72 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $98M | 74 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $138M | 74 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $161M | 85 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $121M | 51 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $149M | 49 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $91M | 37 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $102M | 35 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $209M | 88 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $506M | 97 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $569M | 85 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $544M | 81 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $826M | 78 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DSCQG PR LLC028-18129
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.